Skip to main content
main-content

01.09.2009 | Short Communication | Ausgabe 9/2009

European Journal of Nuclear Medicine and Molecular Imaging 9/2009

18F-Fluoroglucosylation of peptides, exemplified on cyclo(RGDfK)

Zeitschrift:
European Journal of Nuclear Medicine and Molecular Imaging > Ausgabe 9/2009
Autoren:
Christina Hultsch, Margret Schottelius, Jörg Auernheimer, Andrea Alke, Hans-Jürgen Wester

Abstract

Purpose

Oxime formation between an aminooxy-functionalized peptide and an 18F-labelled aldehyde has recently been introduced as a powerful method for the rapid one-step chemoselective synthesis of radiofluorinated peptides.

Materials and methods

Here, the potential of using routinely produced and thus readily available [18F]fluorodeoxyglucose ([18F]FDG) as the aldehydic prosthetic group was investigated using an aminooxyacetyl-conjugated cyclic RGD peptide (cyclo(RGDfK(Aoa-(Boc)) as a model peptide.

Results

The use of [18F]FDG from routine production ([18F]FDGTUM) containing an excess of d-glucose did not allow the radiosynthesis of [18F]FDG-RGD in activities >37 MBq in reasonable yield, rendering the direct use of clinical grade [18F]FDG for the routine clinical synthesis of 18F-labelled peptides impossible. Using no-carrier-added (n.c.a.) [18F]FDG obtained via HPLC separation of [18F]FDGTUM from excess glucose, however, afforded [18F]FDG-RGD in yields of 56–93% (decay corrected) and activities up to 37 MBq. Suitable reaction conditions were 20 min at 120°C and pH 2.5, and a peptide concentration of 5 mM. In a preliminary in vivo biodistribution study in M21 melanoma-bearing nude mice, [18F]FDG-RGD showed increased tumour accumulation compared to the “gold standard” [18F]galacto-RGD (2.18 vs 1.49 %iD/g, respectively, at 120 min after injection), but also slightly increased uptake in non-target organs, leading to comparable tumour/organ ratios for both compounds.

Conclusion

These data demonstrate that chemoselective 18F-labelling of aminooxy-functionalized peptides using n.c.a. [18F]FDG represents a radiofluorination/glycosylation strategy that allows preparation of 18F-labelled peptides in high yield with suitable pharmacokinetics. As soon as the necessary n.c.a. preparation of [18F]FDG prior to reaction with the Aoa-peptide can be implemented in a fully automated [18F]FDG-synthesis, [18F]fluoroglucosylation of peptides may represent a promising alternative to currently used chemoselective one-step 18F-labelling protocols.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Premium-Inhalten der Fachzeitschriften, inklusive eines Print-Abos.

Weitere Produktempfehlungen anzeigen
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 9/2009

European Journal of Nuclear Medicine and Molecular Imaging 9/2009Zur Ausgabe
  1. Das kostenlose Testabonnement läuft nach 14 Tagen automatisch und formlos aus. Dieses Abonnement kann nur einmal getestet werden.

  2. Das kostenlose Testabonnement läuft nach 14 Tagen automatisch und formlos aus. Dieses Abonnement kann nur einmal getestet werden.